Genes that provide tumors with blood

In the 18 August Science St. Croix et al. present an expression analysis of endothelial cells from blood vessels of normal and malignant colorectal tissue (Science 2000, 289:1197-1202). After developing a method for purifying these scarce cells, they use serial analysis of gene expression (SAGE) to identify a host of new pan-endothelial markers that are not expressed in other tissues. Additionally, 46 SAGE tags are elevated tenfold or more specifically in tumor endothelium, and at least 7 of the

By | August 25, 2000

In the 18 August Science St. Croix et al. present an expression analysis of endothelial cells from blood vessels of normal and malignant colorectal tissue (Science 2000, 289:1197-1202). After developing a method for purifying these scarce cells, they use serial analysis of gene expression (SAGE) to identify a host of new pan-endothelial markers that are not expressed in other tissues. Additionally, 46 SAGE tags are elevated tenfold or more specifically in tumor endothelium, and at least 7 of these tumor endothelial markers (TEMs) are associated with genes that affect extracellular matrix formation or remodeling. Many of the TEMs are not expressed in normal resting endothelium, but they are found in the endothelium of other cancers, and, for the most part, in normal growing endothelium. This suggests that cancer angiogenesis is very similar to normal blood vessel growth, but the few differences may be critical for developing anti-cancer therapies.

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS